Le Lézard
Classified in: Business, Covid-19 virus
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lucira Health, Inc. - LHDX


NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX). Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Lucira and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On October 8, 2021, pre-market, Lucira issued a press release reporting that its supply partner Copan Italia SPA announced a recall of its FLOQSwabs included in the LUCIRA COVID-19 All-In-One Test Kit and LUCIRA CHECK IT COVID-19 Test Kit. The press release stated that "[a]ccording to Lucira's records, Test Kits containing the recalled Copan swabs were distributed from April 22, 2021 through September 22, 2021," and that the recalled Copan swabs should not be used and should be disposed.  On this news, Lucira's stock price dropped sharply during intraday trading on October 8, 2021, damaging investors.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com  
888-476-6529 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 01:30
The capacitive stylus market value is set to grow by USD 51.72 million, progressing at a CAGR of 4.18% from 2021 to 2026, as per the latest report by Technavio....

at 01:05
MTIP, the Swiss healthtech focused private equity firm, has today announced the closing of its MTIP Fund II, SCSp ("The fund") at USD $250 million in capital commitments. The oversubscribed fund, which closed above its target of $225 million,...

at 01:00
The bromelain market is expected to witness the emergence of vendors such as Advanced Enzyme Technologies Ltd. and Changsha Natureway Co. Ltd. The market is expected to grow by USD 16.41 billion from 2021 to 2026. The growth momentum of the market is...

at 00:54
National IT Industry Promotion Agency (NIPA) announced that the 2021 IoT KOREA ONLINE BUSINESS MEETING, which was held from November 2nd to 4th, was completed. The event achieved significant export outcomes by arranging 369 business meetings over...

at 00:50
ABB will be hosting its Capital Markets Day today, December 7, starting 12.00 midday CET. At the event, CEO, Björn Rosengren, CFO, Timo Ihamuotila, as well as other members of the Executive Committee, will give an update on ABB's ongoing...

at 00:01
INRIX, Inc., a world leader in transportation analytics and connected car services, today published the 2021 Global Traffic Scorecard that identified and ranked congestion and mobility trends in more than 1,000 cities, across 50 countries as economic...



News published on 15 october 2021 at 20:40 and distributed by: